RN
Highly rated in
13
conditions

Dr. Raul G. Nogueira

Grady Memorial Hospital
Atlanta, GA
Highly rated in
13
conditions
Specialties:Neurology | Radiology
Experience:28 Years
Clinical Trials:Currently Recruiting for 10 Trials
Accepts:New PatientsMedicare
Highly rated in
13
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Raul G. Nogueira's experience treating your condition:
About Dr. Raul G. Nogueira

Raul Nogueira is a Neurologist and a Radiologist in Atlanta, Georgia. Nogueira has been practicing medicine for over 28 years and is highly rated in 13 conditions, according to our data. His top areas of expertise are Stroke, Apoplexy, Fibromuscular Dysplasia (FMD), Stent Placement, and Transmyocardial Revascularization. He is licensed to treat patients in Massachusetts. Nogueira is currently accepting new patients.

His clinical research consists of co-authoring 464 peer reviewed articles and participating in 22 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Raul G. Nogueira it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Raul G. Nogueira accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Oscar
  •  Cigna
  •  Aetna
Locations
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303
Background & Education
Graduate Institution
Other, 1995
Specialties
Neurology
Radiology
Licenses
Psychiatry & Neurology in MA
Hospital Affiliations
UPMC Mercy
Grady Health System
UPMC Presbyterian
Languages Spoken
English
Portuguese
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

22 Clinical Trials
Endovascular Therapy for Low NIHSS Ischemic Strokes
Enrollment Status: Recruiting
Publish Date: December 15, 2022
Intervention Type: Device, Combination Product
Study Drug: Initial medical management
Study Phase: Phase 2/Phase 3
Embotrap eXtraction & Clot EvaLuation & Lesion Evaluation for NeuroThrombectomy
Enrollment Status: Recruiting
Publish Date: November 29, 2022
Intervention Type: Device
A Prospective, Multi-center, Open Label and Single Arm Clinical Investigation to Evaluate the Safety and Efficacy of Using the Zoom Reperfusion System in Thrombectomy Procedures to Treat Acute Ischemic Stroke Patients
Enrollment Status: Recruiting
Publish Date: November 07, 2022
Intervention Type: Device
Study Phase: Not Applicable
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
Enrollment Status: Recruiting
Publish Date: October 26, 2022
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Intravenous rhTNK-tPA Bridging With Endovascular Treatment Versus Endovascular Treatment Alone For Stroke Patient With Large Vessel Occlusion: A Multicenter, Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: October 18, 2022
Intervention Type: Drug, Other
Study Drug: rhTNK-tPA
Study Phase: Phase 2/Phase 3
Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke
Enrollment Status: Recruiting
Publish Date: September 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Phase III, Randomized, Multi-center Clinical Trial That Will Examine Whether Treatment With Intravenous TNK is Superior to Placebo in Patients Who Suffer a Non-large Vessel Occlusion Ischemic Stroke Within 4.5-12 Hours From Time Last Seen Well
Enrollment Status: Recruiting
Publish Date: April 19, 2022
Intervention Type: Drug
Study Drug: Intravenous Tenecteplase
Study Phase: Phase 3
Randomization to EndoVascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Acute Ischemic Stroke Due to Large Intracranial VEssel OcclusioN Trial - DIRECT Thrombectomy vs. Intravenous TNK Plus Thrombectomy
Enrollment Status: Recruiting
Publish Date: April 19, 2022
Intervention Type: Drug
Study Drug: Tenecteplase
Study Phase: Phase 3
Endovascular Therapy vs Medical Management of PosterIor Cerebral Artery Occlusion Stroke
Enrollment Status: Recruiting
Publish Date: April 06, 2022
Randomization of Endovascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke Due to Large VEssel OcclusioN Trial in the Extended Time Window
Enrollment Status: Recruiting
Publish Date: February 10, 2021
Intervention Type: Device
Study Phase: Phase 3
Global Impact of the COVID 19 Pandemic on Stroke Care: 1-year Follow-up Study
Enrollment Status: Completed
Publish Date: November 16, 2022
Intervention Type: Other
pRESET for Occlusive Stroke Treatment
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
ThrombX Retriever for Acute Ischemic Stroke Trial
Enrollment Status: Not yet recruiting
Publish Date: March 28, 2022
Intervention Type: Device
Study Phase: Not Applicable
Standard Medical Treatment Plus Endovascular Treatment Versus Standard Medical Treatment Alone for Stroke Patient With Large Vessel Occlusion In The Posterior Circulation: A Multicenter, Randomized, Clinical Trial
Enrollment Status: Suspended
Publish Date: September 14, 2021
Intervention Type: Procedure, Other
Study Phase: Not Applicable
Stryker Neurovascular Trevo® Retriever Registry
Enrollment Status: Completed
Publish Date: June 24, 2020
A Prospective, Randomized, Open-Label, Multi-Center, Assessor-Blinded Study Designed to Compare the Safety, Performance and Efficacy of the NeVatm Stent Retriever Versus the Solitairetm Stent Retriever
Enrollment Status: Withdrawn
Publish Date: May 21, 2020
Intervention Type: Device
Study Phase: Not Applicable
Randomization of Endovascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke Due to Large VEssel OcclusioN Trial
Enrollment Status: Completed
Publish Date: February 19, 2020
Intervention Type: Device, Procedure
Study Phase: Phase 3
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Enrollment Status: Completed
Publish Date: December 02, 2019
Intervention Type: Device
Study Phase: Not Applicable
Volumetric Impedance to Guide Stroke Response
Enrollment Status: Unknown status
Publish Date: December 07, 2018
Intervention Type: Device
Diffusion Weighted Imaging (DWI) or Computerized Tomography Perfusion (CTP) Assessment With Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention (DAWN)
Enrollment Status: Completed
Publish Date: July 20, 2018
Intervention Type: Other, Device
Study Phase: Not Applicable
ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study
Enrollment Status: Completed
Publish Date: July 13, 2018
Intervention Type: Device
Study Phase: Not Applicable
Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO 2)
Enrollment Status: Completed
Publish Date: August 03, 2015
Intervention Type: Device
Study Phase: Not Applicable
View 12 Less Clinical Trials -
463 Total Publications
Endovascular vs Medical Management for Late Anterior Large Vessel Occlusion With Prestroke Disability: Analysis of CLEAR and RESCUE-Japan.
Journal: Neurology
Published: November 04, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
SF
Dr. Stewart A. Factor
Neurology | Psychiatry
Highly rated in
19
conditions
Neurology
Psychiatry

Emory Healthcare

Emory Brain Health Center

12 Executive Park Dr Ne, 
Atlanta, GA 
 5.8 mi

Stewart Factor is a Neurologist and a Psychiatrist in Atlanta, Georgia. Factor has been practicing medicine for over 41 years and is highly rated in 19 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Tardive Dyskinesia, Drug Induced Dyskinesia, Torticollis, and Deep Brain Stimulation. He is licensed to treat patients in Georgia. Factor is currently accepting new patients.

JG
Dr. Jonathan D. Glass
Neurology
Highly rated in
10
conditions
Neurology

Emory Healthcare

ALS Clinic

12 Executive Park Dr Ne, 
Atlanta, GA 
 5.8 mi

Jonathan Glass is a Neurologist in Atlanta, Georgia. Glass has been practicing medicine for over 38 years and is highly rated in 10 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Abdominal Wall Surgery, and Endoscopy. He is licensed to treat patients in Georgia. Glass is currently accepting new patients.

BB
Dr. Beau B. Bruce
Neurology
Highly rated in
12
conditions
Neurology

Emory Clinic - Ophthalmology

1365b Clifton Rd Ne, 
Atlanta, GA 
 4.0 mi

Beau Bruce is a Neurologist in Atlanta, Georgia. Bruce has been practicing medicine for over 21 years and is highly rated in 12 conditions, according to our data. His top areas of expertise are Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Papilledema, Headache, and Stent Placement. He is licensed to treat patients in Georgia. Bruce is currently accepting new patients.